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Summary
Dietary heme iron is an important nutritional source
of iron in carnivores and omnivores that is more read-
ily absorbed than non-heme iron derived from vege-
tables and grain. Most heme is absorbed in the proxi-
mal intestine, with absorptive capacity decreasing
distally. We utilized a subtractive hybridization ap-
proach to isolate a heme transporter from duodenum
by taking advantage of the intestinal gradient for
heme absorption. Here we show a membrane protein
named HCP1 (heme carrier protein 1), with homology
to bacterial metal-tetracycline transporters, mediates
heme uptake by cells in a temperature-dependent and
saturable manner. HCP1 mRNA was highly expressed
in duodenum and regulated by hypoxia. HCP1 protein
was iron regulated and localized to the brush-border
membrane of duodenal enterocytes in iron deficiency.*Correspondence: andrew.t.mckie@kcl.ac.uk
7 These authors contributed equally to this study.Our data indicate that HCP1 is the long-sought intesti-
nal heme transporter.
Introduction
Iron is essential for nearly all forms of life. In humans,
anemia due to iron deficiency affects millions of people
worldwide. On the other hand, iron overload due to ge-
netic diseases such as hemochromatosis, in which too
much iron is taken up from the diet, is also a serious
health risk. Iron can be absorbed from the diet in two
forms: as inorganic (non-heme) iron predominantly re-
leased from foods such as vegetables or cereals, or
as heme iron from the breakdown of hemoglobin and
myoglobin contained in red meat. Heme (ferrous proto-
porphyrin IX) is more efficiently absorbed than inor-
ganic iron from the diet, and the iron released as a
result of cleavage of the porphyrin ring makes a signifi-
cant contribution to body iron stores (Lynch et al.,
1989). For convenience, we use the term heme here
to indicate iron-protophorphyrin IX irrespective of the
oxidation state of the iron.
Bacteria have developed several strategies to cap-
ture heme and utilize the iron contained within the por-
phyrin ring. These include direct binding of heme and
hemoglobin to outer membrane receptors as well as
capture of hemoglobin and hemopexin via secreted
proteins (reviewed in Genco and Dixon [2001]). In mam-
mals, the duodenal enterocytes and hepatocytes are
major sites of heme transport, although the mechanism
by which heme is transported across the plasma mem-
branes in these cells has remained elusive (Uzel and
Conrad, 1998; Muller-Eberhard, 1988; Smith and Mor-
gan, 1984). Although it has been shown that heme can
diffuse across model lipid membranes due to its hy-
drophobic nature (Light and Olson, 1990), studies in
isolated hepatocytes (Noyer et al., 1998) and in the in-
testinal-like cell line Caco-2 (Worthington et al., 2001)
have demonstrated that heme uptake takes place by a
saturable, carrier-mediated process, indicative of a
heme transporter. Further evidence has been provided
for a specific heme receptor both on duodenal brush-
border membranes and on the plasma membrane of
erythroleukemia cells (Grasbeck et al., 1982; Galbraith
et al., 1985). Recently, two proteins, Bcrp/ABCG2 and
FLVCR, have been implicated in heme export in ery-
throid cells, although their role in intestinal heme ab-
sorption is not known (Krishnamurthy et al., 2004; Quig-
ley et al., 2004).
Earlier studies of intestinal heme absorption provided
evidence that heme binds to the brush-border mem-
brane of duodenal enterocytes and that the molecule is
translocated intact across the membrane, after which
the heme appears in membrane bound vesicles within
the cytoplasm (Weintraub et al., 1965; Conrad et al.,
1966; Wheby et al., 1970; Parmley et al., 1981; Wyllie
and Kaufman, 1982). The heme is then degraded by
heme oxygenase (HO) to yield ferrous iron (Raffin et al.,
1974), which then enters the low molecular weight pool
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790of iron in the enterocyte, along with iron absorbed as
inorganic (i.e., non-heme) iron, and exits the enterocyte
via the basolateral transporter ferroportin (McKie et al.,
2000; Donovan et al., 2000; Abboud and Haile, 2000).
As with the absorption of inorganic iron, the epithelial
cells of the duodenal mucosa play a key role in dietary
heme absorption and have the highest capacity to take
up heme compared to other regions such as ileum,
which has the lowest absorptive capacity for heme ab-
sorption (Wheby et al., 1970). We utilized a subtractive
hybridization approach to isolate a heme transporter
from duodenum by taking advantage of the intestinal
gradient for heme absorption. Here, we describe the
properties and regulation of a putative intestinal heme
transporter (HCP1).
Results
HCP1 Encodes a Protein with Homology to Bacterial
Tetracycline-Resistance Proteins
HCP1 was isolated from mouse duodenum using sup-
pression subtractive hybridisation (Diatchenko et al.,
1996). A similar approach has led to the identification
of two other proteins involved in the intestinal absorp-
tion of non-heme iron, ferroportin, and Dcytb (McKie et
al., 2000, 2001). To isolate HCP1, the experiment was
performed by subtraction of ileal cDNA from duodenal
cDNA using hypotransferrinaemic mice (trf hpx/hpx) as
previously described (McKie et al., 2000, 2001). The
murine HCP1 cDNA (1942bp) encodes a protein of 459
amino acids (50 kDa), with nine predicted transmem-
brane domains (Figures 1A and 1C). The mouse HCP1
gene spans five exons and is located on mouse chro-
mosome 11B5. The human gene is 2097 bp in length
and encodes 459 AA, spans five exons, and is located
on chromosome 17q11.1. A multiple alignment of HCP1
protein sequences from various species including Ze-
brafish shows that the protein is highly conserved (Fig-
ure 1A). BLAST searches of the protein databases re-
vealed that HCP1 had significant homology (score =
41.3 bits [96], expect = 0.024, identities = 80/345 [23%],
positives = 130/345 [37%], gaps = 27/345 [7%]) to bac-
terial metal tetracycline transporters, which have 12
transmembrane (TM) domains and are members of the
major facilitator superfamily (MFS). The homology be-
tween HCP1 and metal tetracycline transporters ex-
tended over a large part of the molecule (345 amino
acids or 75% of the HCP1 molecule), including both
transmembrane and nontransmembrane regions (Fig-
ure 1A). This homology may, in part, be due to similari-
ties in the structures of heme and the metal tetracycline
complex (Figure 1B).
HCP1 Mediates Heme Uptake
To determine whether HCP1 was capable of heme
transport, we expressed the protein in Xenopus oo-
cytes and measured heme uptake at RT (20°C) and 4°C
using 55Fe-heme liganded with either L-arginine or
BSA. In oocytes injected with HCP1 cRNA, we ob-
served a 2.5-fold increase (p < 0.0001) in 55Fe-heme
uptake at 20°C compared to water-injected controls
when L-arginine was used as the ligand (Figure 2F).
When BSA was substituted as the heme donor, total
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cptake was reduced approximately 10-fold but re-
ained significantly (p = 0.01) above control (data not
hown). These results indicated that both heme-argi-
ine and heme-BSA were able to donate heme for up-
ake via HCP1. In experiments conducted at 4°C, 55Fe-
eme uptake by oocytes expressing HCP1 was greatly
educed, indicative of an energy-dependent process
data not shown). Varying the pH of the uptake buffer
rom 6.5 to 8.5 had no significant effect on heme uptake
nto oocytes (data not shown).
We next investigated the properties of 55Fe-heme up-
ake in cultured HeLa cells infected or not with HCP1
denovirus. Due to the apparent toxicity of the HCP1
denovirus to HeLa cells (see far right panel, Figure 3A),
e were unable to use high virus titres for uptake ex-
eriments. We found that using a relatively low virus
itre resulting in 5%–10% infection of cells measured
y antibody staining (panel marked by an arrow in Fig-
re 3A) was sufficient to observe a consistent 2- to
-fold increase in heme transport above background
ithout significantly affecting cell viability. A time
ourse of 55Fe-heme uptake was performed in both un-
nfected and HCP1-infected HeLa cells at 37°C and 4°C
Figure 2A) using a heme concentration of 2.0 M. In
CP1-infected cells, uptake of 55Fe-heme was signifi-
antly increased (4.5 × 10−5 < p < 0.04) at all time points
fter 5 min (Figure 2A). There was an initial steep in-
rease in 55Fe-heme uptake in both HCP1 infected and
ontrol uninfected cells, which appeared to reach a pla-
eau after 20 min. At 4°C, uptake was greatly reduced
n both uninfected and virally transduced cells. Trans-
ort of heme by HCP1 virally transduced cells ap-
eared to be linear over a wide range of heme concen-
rations and was significantly higher (0.0003 < p < 0.04)
han uninfected cells at all concentrations of heme (Fig-
re 2B). Subtraction of the endogenous uptake from the
CP1-induced uptake revealed a saturable component
ith an apparent Vmaxapp of 3.1 pmol/min/g protein
nd Kmapp of 125 M heme (Figure 2C).
To address the specificity of HCP1, we measured up-
ake of 3H-tetracycline and 59Fe (III) in comparison to
5Fe-heme HCP1 infected cells and uninfected cells
Figure 2D). We found that, in contrast to the 2-fold in-
rease in heme uptake (p < 0.001), there was no in-
rease in either 3H-tetracycline or 59Fe(III) transport in
CP1 infected cells, providing additional evidence that
CP1 was specific for heme. In addition, we found that
100× excess cold heme, ZnPP (zinc protoporphyrin)
r PP (protoporphyrin IX), decreased HCP1-dependent
ptake to values indistinguishable from endogenous
ptake (Figure 2E). To show that HCP1 mediated trans-
embrane transport of heme, we utilized the fluores-
ent analog of heme, ZnPP, and measured uptake in
HO cells transfected with HCP1. There was much
tronger fluorescence in HCP1-transfected cells than in
ontrol, indicating greater uptake of ZnPP (Figure 2E,
nset).
Transfection of the CHO cells stably expressing an
CP1-GFP fusion with an HCP1-specific siRNA abol-
shed the HCP1-induced increase in 55Fe-heme uptake
Figure 4A). Confocal image analysis revealed that the
pecific RNAi but not the scrambled oligo markedly re-
uced the HCP1-GFP signal (by FACS analysis, the de-
rease in GFP signal was reduced approximately
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791Figure 1. HCP1 Protein and Related Sequences
(A) Multiple sequence alignments of HCP1 orthologs from mouse (gi 34786034), rat (gi 34872833), human (gi 31543204), rabbit (gi 631600),
and zebrafish (gi 41053617) and homology to three bacterial tetracycline carriers. Boxed regions denote predicted transmembrane regions.
(B) Structural similarities between heme and a metal-tetracycline complex.
(C) Membrane topology of HCP1 showing conserved GXXSDRXGRR motif between TM2 and TM3, fully (red) and partially (blue) conserved
histidine residues.2-fold, data not shown). The scrambled siRNA oligo
itself had no effect on heme uptake in untransfected
cells, which was the same as the no-oligo control (data
not shown). We conclude that HCP1 is capable of me-
diating transmembrane uptake of heme in a temper-
ature-dependent and saturable manner and, moreover,
that the transporter is specific for the porphyrin ring
since uptake was competed by both ZnPP and PP.
To investigate whether the HCP1 antibody could
functionally block intestinal heme transport, we mea-
sured 55Fe-heme uptake in vitro using everted duode-
nal sacs taken from normal and hypoxic mice in the
presence of the HCP1 antibody or preimmune serum.
In normal mice, 55Fe-heme uptake was 1.94 ± 0.33
pmol/mg tissue in everted sacs incubated with preim-
mune sera; however, in the presence of the HCP1 anti-sera, uptake was significantly (p = 0.02) decreased to
1.33 ± 0.18 pmol/mg tissue. In hypoxic mice, in the
presence of preimmune sera, 55Fe-heme uptake was
3.21 ± 1.25 pmol/mg tissue. This was reduced to 1.95 ±
0.51 pmol/mg tissue in the presence of the HCP1 anti-
body (p = 0.037). These data strongly suggest HCP1
plays a direct role in intestinal heme uptake.
Regulation of HCP1 mRNA and Protein in Mouse
Intestine by Iron, Hypoxia, and Hypotransferrinaemia
We screened various mouse tissues for expression of
the HCP1 transcript by Northern blotting. High expres-
sion was found in duodenum with low expression de-
tected in the kidney (Figure 5A). No expression was
seen in mouse duodenum before weaning or in pla-
centa (Figure 5A). Using more sensitive RNase protec-
Cell
792Figure 2. HCP1 Mediates Heme Uptake in Cultured Cells and Xenopus Oocytes
(A) Temperature dependence and time course of heme uptake in uninfected and HCP1-infected HeLa cells. 55Fe-heme uptake (2 uM) was
determined at either 4°C or 37°C at various times indicated.
(B) 55Fe-heme in uninfected cells (HeLa) and adenovirus-infected cells (HeLa-HCP1) as a function of heme concentration.
(C) Subtraction of endogenous heme uptake from HCP1-induced uptake reveals a saturable component.
(D) Comparison of 55Fe-heme uptake with that of 3H-tetracycline and 59Fe(III) in HCP1-infected (black bars) and uninfected (white bars) HeLa
cells. No significant uptake of either tetracycline or Fe(III) was observed in infected cells; *p < 0.001.
(E) Uptake of 55Fe-heme (1 M) over 20 min with no competitor or in the presence of 100 M unlabeled heme, 100 M ZnPP, and 100 M
PP. In HCP1-infected cells (black bars), heme uptake was significantly (p % 0.0001) reduced by all three competitors. Uptake was also
significantly (p < 0.01) reduced by the competitors in uninfected cells (white bars), but to a lesser extent. (Inset) Transport of ZnPP by HCP1-
transfected CHO cells. Cells were incubated with 20 M ZnPP for 20 min and images captured by confocal microscopy; representative field
are shown from untransfected CHO cells and transfected CHO-HCP1 cells.
(F) Uptake of 55Fe-heme (30 M) in Xenopus oocytes incubated at 20°C. Results are from a single representative experiment and are means ± SD
for 15 oocytes in each group (*p < 0.0001). Results were consistent in four separate experiments performed on batches of oocytes harvested
from individual toads. Experiments shown in (A)–(E) were quadruplicate determinations and are representative of three similar experiments.
All data are presented as means ± SD.tion assays, we were able to detect significant HCP1
levels in adult rat liver (data not shown) and also in a
hepatoma cell line (Hepa, see Figure S1 in the Supple-
mental Data available with this article online). A North-
ern blot of RNA from a number of mouse cell lines re-
vealed that a strong 2.0 kb transcript corresponding to
the HCP1 mRNA was detected in a number of cell lines
(Figure S1). Expression varied considerably from unde-
t
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pectable in R1.1, L1210, P388D1, and P815 cells to high
xpression in the hepatoma cell line (Hepa), the neuro-
lastoma cell line (NB41A), and in macrophages
Raw264) (Figure S1).
In contrast to the basolateral iron transporter ferro-
ortin and apical ferric reductase Dcytb (Figure 5A),
either iron deficiency nor systemic iron loading ap-
eared to regulate duodenal HCP1 mRNA levels (Figure
Intestinal Heme Transport
793Figure 3. Expression of HCP1 in HeLa Cells
(A) Expression of HCP1 protein (green) in HeLa cells after overnight incubations with increasing titres of HCP1 adenovirus. Results show a
dose-dependent increase in HCP1 protein expression and also that HCP1 is expressed in the plasma membrane of infected HeLa cells.
Nuclei are stained with propidium iodide (red). Arrow indicates the typical virus titre used for heme uptake assays.
(B) Higher magnification showing typical plasma-membrane-staining pattern.
(C) HeLa cells infected overnight with HCP1 virus and then fixed and stained with HCP1 antisera (green) in the presence of an unrelated
peptide (−) or the HCP1 peptide (+) used to raise the antibody. Virtually no signal was detected in the presence of the HCP1 peptide, whereas
the unrelated peptide had no effect on the signal, indicating the antiserum is specific for HCP1 protein.S2). Further quantitative analysis of duodenal HCP1
mRNA from three individual mice from each group (iron
deficient versus control fed) carried out by Q-PCR
showed a slight increase in HCP1 mRNA in iron defi-
ciency, which did not reach statistical significance (p =
0.06, data not shown). HCP1 mRNA was not detected
in ileum under any condition (Figures 5B and 5C and
Figure S2). In hypotransferrinemic (trf hpx/hpx) mice,
there was a small increase in duodenal mRNA content
in mutant mice compared with wild-type mice (Figure
5C, compare +/− with −/−). Q-PCR performed on mRNA
from duodenum of three homozygotes compared to
three heterozygotes also revealed a small increase,
which did not reach statistical significance (p = 0.08,
data not shown). Exposure of mice to hypoxia for 3
days is known to induce iron absorption (Raja et al.,
1988) and reduce levels of the iron-regulatory peptide
hepcidin in the liver (Nicolas et al., 2002). We found that
hypoxia produced a marked induction in HCP1 mRNA
levels in duodenum (Figure 5B). We have found that ex-
posure to hypoxia does significantly stimulate duode-
nal uptake of 59Fe-heme in vivo compared to normal
mice (48.6 ± 5.1 normal versus hypoxic 66.7 ± 7.2 nmol
heme/mg wt/10 min; SD, p < 0.03). We conclude thatHCP1 mRNA is strongly regulated by hypoxia but ap-
pears less sensitive to changes in iron stores compared
with genes involved in transport of non-heme iron.
In control mice, the HCP1 protein was localized both
in the apical membrane as well as in the cytoplasm
(Figure 6A). However, in iron-deficient mice, there was
a striking localization of the protein at the brush-border
membrane with little or no cytoplasmic staining evident
(Figure 6A). In contrast, in iron-loaded mice, no apical
staining was evident and the protein appeared to accu-
mulate in the cytoplasm of the cell (Figure 6A).
High doses of oral iron given to iron-deficient rats
have been shown to downregulate both mRNA and pro-
tein levels of DMT1 and Dcytb in the duodenum 12–
16 hr after administration (Frazer et al., 2003), while, in
humans, ingestion of oral iron supplements containing
a standard 65 mg of ferrous sulfate has been shown to
produce a rapid (within 3 hr) increase in the serum
levels of the iron-regulatory peptide hepcidin (Nemeth
et al., 2004a). These changes in expression of iron
transporters and serum hepcidin form the molecular
basis of the “mucosal block” phenomenon, in which
high oral doses of iron reduce the absorption of subse-
quent doses (Hahn et al., 1943; Frazer et al., 2003). To
Cell
794Figure 4. Treatment of HCP1-Expressing CHO Cells with HCP1 siRNA Abolishes the HCP1-Induced Increase in Heme Uptake
(A) Bar chart shows that HCP1 siRNA abolished the increase in heme uptake seen with HCP1-GFP. (Aa) P = 0.00004 untransfected versus
HCP1 GFP + scrambled; (Ab) p = 0.00001 HCP1 GFP scrambled versus HCP1 GFP siRNA. Results are means ± SEM performed in sextriplicate.
Experiment shown is representative of three similar experiments.
(B) Confocal images showing that the HCP1 siRNA but not the scrambled oligo knock down the HCP1-GFP signal.investigate whether HCP1 protein was regulated by
high doses of oral iron, we dosed iron-deficient mice
by gavaging (introducing iron directly into the stomach
by a rounded syringe) with iron and performed immuno-
staining on duodenal sections obtained at 0, 3, 16, and
72 hr after the dose was given (Figure 7). At time zero,
HCP1 appeared highly localized at the brush-border
membrane. After 3 hr, HCP1 staining was slightly re-
duced, but there was still strong apical staining of
HCP1. After 16 hr, there was no evidence of HCP1 pro-
tein on the apical membrane, with most staining ap-
pearing in the cytoplasm (Figure 7). This time point
correlated with the highest liver non-heme iron values.
After the iron dose was given (72 hr) there was a recov-
ery of HCP1 protein levels in apical membrane (Figure
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7). We conclude that HCP1 protein subcellular localiza-ion is regulated by a posttranslational mechanism in
esponse to changes in iron stores.
To confirm that HCP1 was localized to the brush bor-
er, we performed immunoelectron microscopy with
olloidal gold using the HCP1 antibody. Sections of du-
denum stained with HCP1 antibody revealed the pres-
nce of gold particles in the brush-border membrane
nd in the apical cytoplasm (Figure 6B, right panel). In
ontrast, no gold particles were detected on the sec-
ions incubated with preimmune sera (left panel, Fig-
re 6B).
iscussion
ur results identify HCP1 as an intestinal heme trans-
porter capable of mediating energy-dependent, trans-
Intestinal Heme Transport
795Figure 5. Northern Blot Analysis
(A) Expression of HCP1 mRNA in various mouse tissues in comparison to mRNAs of proteins involved in non-heme iron absorption (Dcytb
and ferroportin).
(B) Effect of hypoxia on HCP1 expression in duodenum and ileum in wild-type mice under normoxic conditions and following 6, 24, and 72
hr exposure to 0.5 atm pressure.
(C) Intestinal HCP1 expression in trfhpx/hpx mice shows small upregulation of HCP1 in duodenum of −/− mice but no expression in ileum.membrane uptake of the intact metaloporphyrin ring.
HCP1 mRNA was highly expressed in the duodenal mu-
cosa, the main site of intestinal heme absorption, with
virtually no expression in ileum. The HCP1 protein was
highly localized to the apical membrane of the duode-
nal enterocyte, particularly in iron deficiency, and was
posttranslationally regulated in response to changes in
iron stores. Analysis of heme uptake by cells is compli-
cated by the fact that heme will partition into lipid mem-
branes (Light and Olson, 1990) and that free heme
forms aggregates in aqueous solution. We therefore
conducted uptake experiments at both 4°C and 37°C
and made use of the fluorescent analog of heme, ZnPP,
to differentiate between binding/partitioning into mem-
branes and uptake into the cell. At 4°C, there was only
a small rise in heme uptake in HeLa cells as a function
of time and heme concentration in comparison to 37°C.
Transport of heme by HCP1 at 37°C appeared to be
relatively linear over a wide range of heme concentra-
tions, showing saturation at high heme levels, indica-
tive of a carrier-mediated process. Increased uptake of
the heme analog ZnPP in HCP1-transfected CHO cells
strongly indicates that HCP1 is capable of transmem-
brane transport of heme. It should be noted that thetendency of heme to polymerize in solution or bind to
proteins means that, in physiological media, total heme
concentrations likely far exceed the concentration of
free monomeric heme. Thus, kinetic studies, in which
heme concentrations exceed low micromolar, are dif-
ficult.
The observed 2- to 3-fold increase in heme uptake in
both Xenopus oocytes and HeLa cells expressing
HCP1 was relatively small, and we cannot exclude the
possibility that other proteins and/or environmental fac-
tors present in vivo in the duodenum or cultured cells
play a role in heme uptake. Confounding factors we
found in HeLa cells were the following: endogenous,
energy-dependent uptake of heme in uninfected cells
and the limiting effect of using low virus titres. Endoge-
nous heme uptake may have been due to HCP1 itself
or the presence of other heme transporters. The latter
is more likely since we did not observe any reduction
in endogenous 55Fe-heme transport in untransfected
HeLa cells treated with HCP1 siRNA (data not shown).
In CHO cells transfected with HCP1-GFP, the fold in-
crease in heme uptake was less than that observed in
HeLa cells or oocytes. This may have been due to the
GFP tag interfering with the function of the protein and/
Cell
796Figure 6. Regulation of HCP1 Protein Localization in Intestinal Cells
(A) HCP1 localizes to the apical membrane in iron-deficient mouse duodenum and to the cytoplasm after systemic iron loading. Lower panels
show higher magnification images of iron-loaded and iron-deficient duodenal enterocytes. Images are representative of similar results ob-
tained in three independent experiments.
(B) Immunogold staining of EM sections of duodenum from a control mouse showing gold particles in the brush border (right panel). Left
panel is a negative control incubated with the preimmune sera showing no grains.or upregulation of heme efflux proteins such as Bcrp.
The increase in heme uptake was due to HCP1, since
treatment of the cells with the specific siRNA abolished
the increase. Further evidence for a direct role of HCP1
in duodenal heme transport was provided by antibody-
blocking experiments. The results, showing that incu-
b
h
p
e
oation of duodenal tissue with HCP1 antisera reduced
eme uptake in normal mice and abolished the hy-
oxia-induced increase in heme uptake, provide strong
vidence that HCP1 is directly involved in absorption
f dietary heme.
To maintain heme in solution, we made use of various
Intestinal Heme Transport
797Figure 7. HCP1 Protein Is Regulated by a Single High Dose of Oral Iron
Effect of a 200 g oral dose of iron in mice previously maintained on an iron-deficient diet on the subcellular localization of duodenal HCP1
protein 0, 3, 16, and 72 hr after dosing. Liver non-heme iron values (nmol/mg wet weight) from the same mice are also shown under the panels.heme ligands such as L-arginine and BSA. The natural
ligand for heme in the intestinal lumen (following diges-
tion of protein ligand) is not known, but it is likely that
at least some heme would be associated with free
amines of peptides or amino acids. L-arginine is used
to stabilize preparations of heme used for the treatment
of patients with acute hepatic porphyria (Tenhunen et
al., 1987). Arginine binds weakly to heme, forming a
loosely polymeric complex that is bioavailable (Sievers
et al., 1987). BSA binds heme with a low affinity (Kd
10−6 mol/L) (Pasternack et al., 1983) and, therefore, may
reduce the amount of bioavailable or free heme.
We did not observe any induction of either radiolabeled
non-heme iron or tetracycline in virally transduced HeLa
cells, suggesting that neither were transported by HCP1.
Uptake of 55Fe-heme via HCP1 appeared to plateau after
20 min. At the present time, we do not know what the
energy source is for HCP1 (no ATP binding motifs were
found in the sequence), but it is possible that the pla-
teau may reflect exhaustion of an energy substrate or
some other regulatory mechanism. Direct heme efflux
via FLVCR or Bcrp is a possibility. Other members of
the MFS use ion or proton gradients to drive transport
of substrates across membranes. Hence, it is possible
that HCP1 could utilize the strong proton gradient
known to exist in the proximal intestine (McEwan et al.,
1988) to transport heme.
We were unable to detect any of the known heme
binding motifs such as the CXXCH motif found in c-type
cytochromes (Daltrop et al., 2002) or homology to the
heme binding protein hemopexin (Paoli et al., 1999).
However, alignment of HCP1 sequence from different
species did reveal four fully conserved His residues that
could act as heme ligands (Figure 1C). We did not de-
tect a recognizable iron response element (IRE) in either
5# or 3# UTRs of the HCP1 cDNA sequence.
HCP1 displayed relatively high homology to bacterial
tetracycline transporters. A particularly highly con-
served motif, GXXSDRXGRR, present between TM2
and TM3 is found in all metal-tetracycline transporters
and in all HCP1 sequences from five species (Figure
1C, circled amino acids). The motif is also found inother multi-drug-resistance transporters and proton-
associated sugar transporters within the MFS, and mu-
tation of either Gly residue in tetracycline resistance
proteins abolishes metal-tetracycline transport function
(Yamaguchi et al., 1992). This motif is also present in
the recently described protein FLVCR, involved in heme
efflux in erythroid precursor cells (Quigley et al., 2004).
In gram-negative bacteria, primary resistance to tetra-
cycline is based on active efflux of a metal-tetracycline
complex in exchange for a proton (Yamaguchi et al.,
1990). In order for tetracycline efflux to occur, the anti-
biotic must be bound by a divalent cation such as Co2+,
Mn2+, or Mg2+ (Yamaguchi et al., 1990). It is known that
any of the following divalent cations can form stable
1:2 complexes with tetracycline Fe2+, Cu2+, Ni2+, Co2+,
Zn2+, Mn2+, or Mg2+ (Ditchburn and Pritchard, 1956)
with the metal in the center (depicted in Figure 1B). It
is interesting to note the similarities in structure of a
metal [tetracycline]2 complex, the likely substrate for
the resistance proteins, and that of heme (Figure 1B).
The molecular weight of heme is 645.7, compared to
978.9 for a tetracycline iron complex, and both mole-
cules are predominantly planar hydrophobic structures,
each possessing one hydrophilic edge.
Expression of HCP1 mRNA was found at several sites
of known heme transport, notably the duodenum and
the liver, with weak expression in kidney. In the circula-
tion, any free heme resulting from hemolysis is rapidly
bound by the serum proteins hemopexin and albumin,
whereas free hemoglobin is bound by haptoglobin.
These complexes are rapidly cleared in the liver by dis-
tinct mechanisms. Hemoglobin-haptoglobin uptake takes
place in macrophages expressing the CD163 receptor
(Kristiansen et al., 2001). Heme-hemopexin complexes
interact with the plasma membrane of the hepatocyte
by a mechanism that has not been fully characterized
involving uptake of the heme and release of the free
hemopexin (Smith and Morgan, 1981). A third mecha-
nism involving a heme transporter expressed in hepato-
cytes capable of transport of heme bound to albumin
has also been described (Noyer et al., 1998). We did not
measure HCP1-mediated heme uptake from the heme-
Cell
798hemopexin complex, but we did observe uptake of
heme from heme-BSA complexes. It is possible that
HCP1 could play an additional physiological role in the
liver by clearance of heme bound to plasma albumin.
In kidney, it has been suggested that filtered hemoglo-
bin may be reabsorbed in the proximal tubule to pre-
vent iron loss and as an antibacterial mechanism, by a
process involving binding of hemoglobin to megalin
and cubilin receptors (Gburek et al., 2002). Our data
would suggest that HCP1 expression in kidney may
also play a role in scavenging any free heme.
Iron stores, hypoxia, and rate of erythropoesis are
well-known stimulators of dietary inorganic iron ab-
sorption; however, less is known about their effects on
heme absorption. Studies in human subjects have
shown that the magnitude of change in intestinal heme
absorption in response to changes in iron stores is less
than for inorganic iron absorption (Turnbull et al., 1962;
Lynch et al., 1989). In rats, some investigators have
found no effect of iron deficiency on duodenal heme
uptake, while others have found 2- to 3-fold and 10-
fold increases (Conrad et al., 1966; Bannerman, 1965;
Wheby et al., 1970; Roberts et al., 1993). The reasons
for these discrepancies are not clear; however, method-
ological differences and/or strain of rat are likely fac-
tors. Regulation of inorganic iron absorption in re-
sponse to changes in iron stores involves changes in
gene expression of duodenal iron transporters DMT1
and ferroportin and auxiliary proteins Dcytb and Heph-
aestin, but also posttranslational changes in the sub-
cellular localisation of transporters (McKie et al., 2000,
2001; Frazer et al., 2002; Trinder et al., 2000; Canonne-
Hergaux et al., 2000). In the present study, we found no
significant increases in HCP1 mRNA in response to
either iron deficiency or increased ineffective eryth-
ropoesis (hpx mice), but we did observe regulation of
HCP1 protein at the brush-border (apical) membrane.
The HCP1 protein shifted from the apical membrane to
the cytoplasm of the duodenal enterocyte in response
to changes in iron stores induced either by high doses
of dietary iron or systemic iron loading, in a similar
manner to proteins involved in non-heme iron transport.
This suggests that iron stores may regulate intestinal
heme transport via posttranslational regulation of HCP1
protein. The nature of this regulatory mechanism has
yet to be fully understood; however, the recent demon-
stration that iron-regulatory peptide hepcidin binds to
the ferroportin protein, causing its internalization and
degradation (Nemeth et al., 2004b), is important. This
would lead to increased intracellular iron levels, which
may be the trigger for a cascade of events resulting in
changes in the subcellular localization of iron transpor-
ters in the enterocyte. The recovery of HCP1 staining in
the apical membrane of iron-deficient mice 72 hr after
giving the oral iron is consistent with the time required
for clearance of the iron and formation of new entero-
cytes and was also observed with DMT1 and Dcytb
proteins (Frazer et al., 2003). We found that hypoxia had
a significant effect on HCP1 mRNA levels and on heme
iron absorption in vivo. We are unable to say whether
increased HCP1 mRNA in response to hypoxia was due
to a direct effect of hypoxia on HCP1 transcription, as
there were no detectable HIF-1 elements within the pro-
moter sequence of HCP1.
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hThe recent demonstration that two distinct proteins,
he ABC transporter Bcrp/ABCG2 and the receptor for
eline leukaemia virus (FLVCR), are involved in heme ef-
lux from hematopoetic cells is noteworthy (Krishna-
urthy et al., 2004; Quigley et al., 2004). The FLVCR
rotein, like HCP1, is also a member of the MFS and
ontains a conserved motif similar to GXXSDRXGRR
etween TM2 and TM3, whereas Bcrp/ABCG2 is an
BC transporter. Both reports suggest that Bcrp and
LVCR are involved in heme efflux, whereas our data
ould suggest HCP1 is involved in heme uptake. Nei-
her report investigated expression and/or regulation of
he respective mRNAs and proteins in response to iron
n the duodenum or in other tissues or directly impli-
ated the proteins in intestinal heme transport. It is
hought that most absorbed heme is broken down by
uodenal HO-1 to yield ferrous iron and that there is
ittle or no efflux of intact heme from the enterocyte to
he circulation (Raffin et al., 1974; Turnbull et al., 1962).
rythroid cells appear to be different in this respect,
nd it would be of interest to investigate intestinal heme
ransport in Bcrp−/− mice or in cats infected with the
eline leukemia virus C. It is possible that an additional
ecretory pathway for heme or metabolite of heme ex-
sts in intestinal cells. Evidence for a secretory pathway
or heme has been suggested recently in the intestinal-
ike cell line Caco-2 (Uc et al., 2004). However, the phys-
ological significance of this pathway in vivo is not
nown.
The identification of HCP1 provides the long-sought-
fter mechanism by which heme iron can be acquired
rom the diet. It is likely that mutations in the HCP1
ene would alter the ability of the gut to absorb dietary
eme iron and, therefore, would be an important deter-
inant of iron stores, particularly in iron overload dis-
ases such as hereditary hemochromatosis. The com-
on form of hereditary hemochromotosis (HFE C282Y)
s known to have a low penetrance, and, therefore,
olymorphisms in genes like HCP1 could affect the
anifestation of the disease. Little is known about the
echanism of transport of free heme across cell mem-
ranes, notably the mitochondrial membrane; hence,
he identification of HCP1 and related proteins may
ave wider implications for heme transport in other tis-
ues and organelles.
onclusions
e have identified an iron-regulated intestinal heme
ransporter. The HCP1 protein sequence shares homol-
gy with bacterial tetracycline efflux transporters, a fact
hat may be related to the similarities in structure of the
ubstrates transported. HCP1-mediated heme uptake
as temperature dependent, saturable, and abolished
y HCP1-specific siRNA and did not transport either
ree iron or tetracycline. Moreover, duodenal heme up-
ake was inhibited by incubation with HCP1 antisera,
ndicating that HCP1 is directly involved in intestinal
eme transport. Results using temperature shifts and
nPP indicated that HCP1-mediated heme uptake rep-
esented transport of heme into the cell. HCP1 mRNA
as highly expressed in duodenal mucosa and ap-
eared not to be iron regulated but was induced by
ypoxia. The subcellular localization of HCP1 protein
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799within the duodenal enterocyte was markedly influ-
enced by iron status and in iron deficiency was local-
ized at the apical membrane, whereas iron loading re-
sulted in movement of the protein to the cytoplasm.
Experimental Procedures
Cloning of HCP1
To isolate HCP1, tfrhpx/hpx mice were used, since these mice have
a highly increased rate of erythropoesis (Huggenvik et al., 1989),
low levels of circulating hepcidin (Weinstein et al., 2002), and, con-
sequently, a very high rate of iron absorption (McKie et al., 2000).
Although heme iron absorption has, to our knowledge, not been
measured in these mice, we assumed that this would also be
upregulated. Since heme absorption is highest in the duodenum
and much lower in ileum (Wheby et al., 1970), we subtracted ileal
cDNA from duodenal cDNA in a homozygote mouse. The sub-
tracted cDNA library was constructed using PCR-Select (BD Bio-
sciences) as previously described (McKie et al., 2000). Briefly, tar-
get (tester) cDNA was synthesized from duodenum of a tfrhpx/hpx
mouse. Nontarget (driver) cDNA was synthesized from the ileum of
the same mouse. The subtracted library was cloned into a TA vec-
tor (Invitrogen). Expression of library clones was validated by
Northern blot analysis. Using this approach, a 245 bp fragment of
HCP1 (original clone name DI9 for duodenum-ileum clone 9) was
isolated. Full-length cDNAs of both murine and human HCP1 (gi
34786034 and 31543204, respectively) were found by conducting a
BLAST search with this sequence against the GenBank database.
Northern Blotting and RT-PCR
Total RNA was extracted from tissues and Northern blotting was
carried out as previously described (McKie et al., 1996). The mouse
cell line mRNA blot was obtained from Clontech BD Biosciences.
A PCR product of the full-length HCP1 cDNA was used as a probe.
Iron status of these mice was confirmed by measuring liver non-
heme iron levels and by probing the same blot with probe for
transferrin receptor, whose mRNA was strongly upregulated in iron
deficiency and downregulated in iron loading (McKie et al., 1996).
Quantitative RT-PCR was carried out using an ABI Prisim 7000 de-
tection system using a one-step RT-PCR protocol with Sybr green
(ABI). Results were standardized using 18 s ribosomal RNA and
β-actin.
55Fe-Heme Uptake in Xenopus Oocytes
Xenopus oocytes were prepared for injection as previously de-
scribed (McKie et al., 2001). To synthesize HCP1 cRNA, the murine
HCP1 ORF was PCR amplified and cloned into the vector pcDNA
3.1 D/V5-His-Topo (Invitrogen). This clone was sequenced in both
directions using appropriate forward and reverse sequencing prim-
ers. The construct was linearized and cRNA transcribed from the
T7 RNA polymerase promoter site using a commercial kit (Ambion).
Oocytes were injected with 30 ng of cRNA. Controls were injected
with the same volume of water. Oocytes were incubated for 2 hr at
RT in 50 l of modified Barths’ saline solution (80 mM NaCl, 1 mM
KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM HEPES [pH 7.4]) containing
27 M 55Fe-heme. 55Fe-heme (1.79 mg, specific activity 0.28 mCi/
mg, RI Consultant LLC, Hudson, New Hampshire) was dissolved in
100 l of methanol:chloroform:acetic acid (89:10:1). To maintain
heme in the monomeric form and prevent precipitation, a working
solution was prepared by adding 1 l of the 55Fe-heme stock to
100 l of 200 mM arginate buffer at pH 8.0. This solution, equivalent
to 27 M heme, was prepared fresh prior to each experiment and
added to the Barths’ medium for oocyte incubations. In experi-
ments using BSA as a heme ligand, arginate was replaced with
0.1% BSA.
Generation of Adenoviral HCP1 Plasmid
HEK 293, HeLa, and CHO cells were obtained from the American
Type Culture Collection (ATCC) and were maintained in growth me-
dium (DMEM) supplemented with 10% fetal calf serum and 100
U/ml penicillin and 100 U/ml streptomycin at 37°C in 5% CO2. The
murine HCP1/pcDNA3.1 V5 topo vector was cut with Kpn1 and
Xba1 and the HCP1-containing fragment ligated into the pShuttle-CMV pAdEasy-1 vector (Stratagene, La Jolla, California). The resul-
tant plasmid was linearized with Pme1, capped with alkaline phos-
phatase, and gel purified. This linearized plasmid (1 ul, w0.05 g)
was transformed into electrocompetent E. coli BJ5183-AdEasy1
cells. HEK 293 cells were plated to 50%–70% confluency in 100
mm plate 24 hr before transfection. Recombinant adenoviral HCP1
DNA vector (5 g), digested with Pac1 and ethanol precipitated,
was transfected into HEK 293 cells using Effectene transfection
reagent (Quiagen). Cells were monitored for lysis and harvested for
viruses after 7 days.
Uptake of 55Fe-Heme in HeLa Cells
For 55Fe-heme uptake experiments, HeLa cells were grown to con-
fluency in 24-well plates. Cells were infected overnight with virus
titer sufficient to induce significant expression of HCP1 protein in
approximately 5%–10% of cells. A trace amount of 55Fe-heme (RI
Consultant LLC, Hudson, New Hampshire) was added to a stock
solution of 2 mM heme (Sigma) dissolved in 0.1 N NaOH. This solu-
tion was diluted in HBSS containing 100 mM arginine to the re-
quired final concentration of 55Fe-heme. Experiments were termi-
nated by removing the 55Fe-heme incubation medium and washing
cells once with ice-cold HBSS containing 1% BSA, followed by
three more washes with ice-cold HBSS alone. Cells were solubi-
lized in 500 uL of 2% sodium deoxycholate in Tris buffer (pH 8).
Aliquots (20 l) were removed for protein analysis and the rest were
transferred into vials containing liquid scintillant. Radioactivity was
determined by scintillation counting (EG&G Wallac). For uptake
studies using other isotopes,3H-tetracycline (Sigma) was made up
in ethanol and a trace amount of 59Fe (NEN) was added to 10 M
Fe-NTA prepared at a ratio of 1:2 from stock solutions of 10 mM of
FeCl3 in 0.01 HCl and 10 mM NTA solution.
For zinc protoporphyrin (ZnPP) uptake studies, CHO cells were
stably transfected with a plasmid containing HCP1 as a GFP fusion
(pEGFP-HCP1). A stock of 0.3 mM ZnPP (Porphyrin Products, Lo-
gan) was prepared as previously described (Worthington et al.,
2001). Cells were incubated for 20 min in 20 M ZnPP in HBSS. To
remove surface bound ZnPP, cells were washed once with ice-cold
HBSS containing 5% BSA followed by three further washes with
HBSS alone. Images were captured using on a Biorad 1024 confo-
cal microscope.
siRNA Treatment of HCP-GFP-Expressing CHO Cells
Transfection of CHO cells was carried out using the siPORT NeoFX
transfection protocol (Ambion Inc.) according to manufacturer’s in-
structions. Briefly, siPORT NeoFX was incubated in Opti-MEM me-
dium for 10 min at RT. The siRNA oligo or negative control scram-
bled oligo was also diluted in Opti-MEM medium to give a final
concentration of 100 nM and mixed 1:1 with the siPORT NeoFX for
a further 10 min incubation at RT. The mixture (50 l) was placed
in each well of a 24-well plate and overlayed with 1 × 105 cells/ml
(450 l) in normal growth medium. Uptake assays were carried 48
hr posttransfection.
Immunohistochemistry
To generate antisera to HCP1, the peptide [C]KVNPHPEFQQFPQSP
corresponding to amino acids 444–459 of mouse HCP1 was syn-
thesized by N-term conjugation with MBS and injected into rabbits
(Sigma Genosys). Immunocytochemistry was performed as pre-
viously described (McKie et al., 2001) using unpurified antiserum.
Electron Microscopy
Duodenal samples were fixed in 4% formaldehyde in 0.1 M PIPES
buffer, infiltrated with 2.3 M sucrose and cryofixed in liquid nitro-
gen. Cryosections 70 nm thick were cut using an RMC CRX cryo-
ultramicrotome and collected using the Tokuyasu technique (Toku-
yasu, 1986). Thawed sections were incubated for 1 hr with primary
rabbit antibody, washed, and then incubated with 10 nm gold-con-
jugated antiserum (Aurion, The Netherlands). The sections were
mounted in a mixture of methyl cellulose and uranyl acetate (nine
parts 2% methyl cellulose: 1 part 3% aqueous uranyl acetate). Ex-
amination was performed using a JEOL 1200 electron microscope.
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Male mice (6- to 9-week-old) of the CD-1 and genetic strains were
used for experimental manipulations of iron status as previously
described (McKie et al., 2000). Oral gavaging was carried out by
dosing mice with 200 g iron as ferrous sulfate made up in water.
Liver non-heme iron values were carried out by TCA extraction of
iron from liver samples and the iron level determined spectrophoto-
metrically as previously described (McKie et al., 2000).
59Fe-Heme Uptake in Mice
Male mice, CD1 strain, 6–8 weeks old (Charles Rivers, Margate,
Kent), were used in this study. Radioiron (supplied as 59FeCl3) was
obtained from Perkin Elmer Life Sciences, Inc. (Boston, Massachu-
setts; specific activity 185 GBq/g). To make 59Fe-heme, a male
Wistar rat was injected ip with 3.7 MBq 59Fe citrate and housed in
a metabolic cage for 1 week. The animal was bled and the red cells
washed three times in 10 volumes of saline and then lysed in 10
volumes of distilled water. Heme was then isolated from the hemo-
globin by crystallization using the method of Labbe and Nishada
(Labbe and Nishida, 1957). In situ tied-off duodenal segments were
used to determine intestinal heme iron absorption as described
(Raja et al., 1987). Animal procedures were approved by the UK
Home Office.
Antibody Blocking Experiments using Everted
Duodenal Segments
Mice exposed to normoxia or 3 days hypoxic (0.5 atm in a hypo-
baric chamber) were anaesthetized and the duodenum removed
(the first 10 cm of the small intestine distal to the bile duct opening).
Following the removal and clearance of any connective tissues and
mesenteries, the intestinal segment was washed with ice-cold
0.15 M sodium chloride and then inverted longitudinally so as to
expose the mucosal surface. Two tied-off loops were made from
each segment by closing the two end parts. After rinsing in 1 ml of
oxygenated physiological medium (125 mM NaCl, 3.5 mM KCl,
1 mM CaCl2, 10 mM MgSO4, 10 mM D-glucose in 16mM HEPES-
NaOH buffer [pH 7.4]), the loops were incubated at 37°C in oxygen-
ated physiological medium containing (0.5C as 55Fe-heme) as a
heme arginate (10 M) with either preimmune serum as a control
or HCP1 antisera at a dilution of 1:100 added to the incubation
medium. After 10 min incubation, the uptake was terminated by
rinsing the tissue in ice-cold Hank’s solution (Sigma) and then three
times in 1% BSA for 1 min each. These rinses are optimal for re-
moval of the maximum adherent heme without loosing of intracellu-
lar radioactivity. After reblotting and weighing, the tissue were so-
lublized, and radioactivity was assayed in the tissue and in 10 l
aliquots of the incubating medium using a twin channel β counter
(LKB Wallac-1209). The results were expressed as pmol/mg wet
tissue.
Statistical Analysis
Data are presented as means ± SEM or SD where indicated.
Groups were compared using Student’s t test. Nonlinear regression
analysis (Figure 2C) was performed using Sigma Plot using a one-
site saturation ligand binding curve (equation, y = VmaxX/Kd + X).
Supplemental Data
Supplemental Data include two figures and can be found with this
article online at http://www.cell.com/cgi/content/full/122/5/789/
DC1/.
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